|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Formation and operating costs | ||||
| Operating Expenses | ||||
| Research and development | ||||
| General and administrative | ||||
| Total operating expenses | ||||
| Loss from operations | ||||
| Interest expense | ||||
| Income on Trust account | ||||
| Net loss and comprehensive loss | ||||
| Total net loss and comprehensive loss | ||||
| Net loss per share, basic | ||||
| Redeemable Ordinary Shares | ||||
| Non-redeemable Ordinary Shares | ||||
| Total net loss per share, basic | ||||
| Net loss per share, diluted | ||||
| Redeemable Ordinary Shares | ||||
| Non-redeemable Ordinary Shares | ||||
| Total net loss per share, diluted | ||||
| Weighted average shares of common stock outstanding, basic | ||||
| Redeemable Ordinary Shares | ||||
| Non-redeemable Ordinary Shares | ||||
| Total weighted average shares of common stock outstanding, basic | ||||
| Weighted average shares of common stock outstanding, diluted | ||||
| Redeemable Ordinary Shares | ||||
| Non-redeemable Ordinary Shares | ||||
| Total weighted average shares of common stock outstanding, diluted | ||||
Loading...